The efficacy of inhibiting metastases in HCC, which was also reported by Jia Wang et al., was confirmed by the identification of differentially expressed genes such as CDH1, CD36, and ICAM1 in our study. This evidence concerns the gene CDH1 and hepatocellular carcinoma.